Glassman Wealth Services Genmab A/S Transaction History

Glassman Wealth Services

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$27.94 - $35.44 $4,861 - $6,166	-174 Reduced 36.4%	304 $9,000
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $3,280 - $3,928	93 Added 24.16%	478 $16,000
Q2 2023 Aug 08, 2023	BUY	$37.4 - $42.94 $1,234 - $1,417	33 Added 9.38%	385 $14,000
Q1 2023 May 04, 2023	SELL	$34.88 - $43.22 $3,139 - $3,889	-90 Reduced 20.36%	352 $13,000
Q4 2022 Feb 06, 2023	BUY	$33.8 - $47.06 $4,427 - $6,164	131 Added 42.12%	442 $18,000
Q3 2022 Nov 09, 2022	BUY	$31.52 - $373.61 $5,894 - $69,865	187 Added 150.81%	311 $10,000
Q2 2022 Aug 04, 2022	SELL	$26.83 - $38.57 $2,602 - $3,741	-97 Reduced 43.89%	124 $4,000
Q1 2022 Apr 14, 2022	BUY	$30.95 - $39.68 $278 - $357	9 Added 4.25%	221 $8,000
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $3,228 - $4,240	90 Added 73.77%	212 $8,000
Q3 2021 Nov 10, 2021	BUY	$41.55 - $48.72 $914 - $1,071	22 Added 22.0%	122 $5,000
Q2 2021 Aug 04, 2021	BUY	$32.88 - $44.57 $2,202 - $2,986	67 Added 203.03%	100 $4,000
Q1 2021 May 05, 2021	SELL	$30.92 - $44.4 $3,308 - $4,750	-107 Reduced 76.43%	33 $1,000
Q4 2020 Feb 04, 2021	BUY	$33.66 - $40.76 $3,197 - $3,872	95 Added 211.11%	140 $6,000
Q3 2020 Nov 09, 2020	BUY	$33.07 - $38.68 $892 - $1,044	27 Added 150.0%	45 $2,000
Q2 2020 Aug 06, 2020	BUY	$20.05 - $33.89 $120 - $203	6 Added 50.0%	18 $1,000
Q4 2019 Feb 07, 2020	BUY	$18.88 - $24.14 $226 - $289	12 New	12 $0

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.